| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4007692 | Archivos de la Sociedad Española de Oftalmología | 2011 | 4 Pages |
Abstract
Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin® injection to be inactivated, after one year of follow-up.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
X. Valldeperas, R. Bonilla, M.R. Romano, J. de la Cámara,